Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Other 3Genitourinary 3Classical hematology 3Gastrointestinal 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 71Pituitary Neoplasms 47Thyroid Cancer, Papillary 28Multiple Endocrine Neoplasia Type 1 21Carcinoma, Neuroendocrine 21Pheochromocytoma 18Paraganglioma 14Thyroid Neoplasms 13Carcinoid Tumor 13Neoplasm Metastasis 12Differentiated Thyroid Cancer 12Adrenocortical Carcinoma 11Neoplasms 10Thyroid Carcinoma, Anaplastic 9Pancreatic Neoplasms 8Insulinoma 8Adrenal Gland Neoplasms 8Pituitary Diseases 6Lung Neoplasms 6Hyperaldosteronism 6Gastro-enteropancreatic neuroendocrine tumor 6Acromegaly 6Stomach Neoplasms 5Prostatic Neoplasms 5Prolactinoma 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5Breast Neoplasms 5Adrenocortical Adenoma 5Adenoma, Islet Cell 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Osteoporosis × Endocrine × Clear all
NCT04719572 2021-01-25

Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

Chinese PLA General Hospital

Phase NA Unknown
180 enrolled
Endocrine

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡